Search Results - "Luz Tarín-Arzaga"

Impact of the affordability of novel agents in patients with multiple myeloma: Real‐world data of current clinical practice in Mexico by Tarín‐Arzaga, Luz, Arredondo‐Campos, Daniela, Martínez‐Pacheco, Victor, Martínez‐González, Odra, Ramírez‐López, Alba, Gómez‐De León, Andrés, Gutiérrez‐Aguirre, Cesar Homero, Cantú‐Rodríguez, Olga, Jaime‐Pérez, José Carlos, Gómez‐Almaguer, David

“…BACKGROUND The treatment of multiple myeloma (MM) has become costly and difficult to access for patients living in low‐income to middle‐income countries…”
Get full text

Reduced‐dose plerixafor as a mobilization strategy in autologous hematopoietic cell transplantation: a proof of concept study by Gutiérrez‐Aguirre, Cesar Homero, Alvarado‐Navarro, Dalila Marisol, Palomares‐Leal, Alain, Mejía‐Jaramillo, Gerardo, Salazar‐Riojas, Rosario, León, Andrés Gómez‐De, Colunga‐Pedraza, Perla Rocío, Sotomayor‐Duque, Guillermo, Jaime‐Pérez, José Carlos, Cantú‐Rodríguez, Olga Graciela, Carmen Tarín‐Arzaga, Luz, Flores‐Jiménez, Juan Antonio, Gómez‐Almaguer, David

“…BACKGROUND Autologous stem cell transplantation (ASCT) is an effective treatment for patients with relapsing myeloma or lymphoma, diseases associated with…”
Get full text

Danazol as first-line therapy for aplastic anemia by Jaime-Pérez, José Carlos, Colunga-Pedraza, Perla R., Gómez-Ramírez, Cynthia D., Gutiérrez-Aguirre, César H., Cantú-Rodríguez, Olga G., Tarín-Arzaga, Luz C., Gómez-Almaguer, David

“…Immunosuppressive therapy (IST) with anti-thymocyte globulin (ATG) plus cyclosporine A (CsA) is the standard treatment for aplastic anemia (AA) patients not…”
Get full text

Romiplostim, low‐dose rituximab and high‐dose dexamethasone for newly diagnosed immune thrombocytopenia: A pilot study by Colunga‐Pedraza, Perla R., De la Garza‐Salazar, Fernando, Vaquera‐Alfaro, Héctor A., Gómez‐De León, Andrés, Bustillos‐Muñoz, Mónica, Tarín‐Arzaga, Luz, Cantú‐Rodríguez, Olga, Gutiérrez‐Aguirre, César Homero, Gómez‐Almaguer, David

“…Therapies such as corticosteroids, thrombopoietin receptor agonists and immunomodulators have been consistently under the spotlight in the search for a better…”
Get full text

Is there a benefit to adding rituximab to CHOP in the overall survival of patients with B-cell non-Hodgkin's lymphoma in a developing country? by Ruiz-Delgado, Guillermo J, Gómez-Almaguer, David, Tarín-Arzaga, Luz C, Cantú-Rodriguez, Olga G, Urdaneta, Carlos Alarcón, Rodríguez-Morales, Uxmal, Calderón-Garcia, Jackeline, Fernández-Vargas, Omar, Montes-Montiel, Maryel, Sánchez-Cárdenas, Mónica, Ruiz-Argüelles, Guillermo J

“…Rituximab (R) has changed the prognosis of patients with non-Hodgkin's lymphoma (NHL) in developed countries, but its role has not been analyzed in…”
Get more information

Treatment of hairy cell leukemia: long-term results in a developing country by Ruiz-Delgado, Guillermo J, Tarín-Arzaga, Luz C, Alarcón-Urdaneta, Carlos, Calderón-García, Jacqueline, Gómez-Almaguer, David, Ruiz-Argüelles, Guillermo J

“…Twenty-nine consecutive patients with hairy cell leukemia (HCL) were treated in two institutions with interferon (IFN, n = 18) or cladribine (n = 11), between…”
Get more information

Performance of serum procalcitonin as a biochemical predictor of death in hematology patients with febrile neutropenia by Reyes Mondragón, Alan Ledif, Cantú-Rodríguez, Olga Graciela, Garza-Acosta, Andrea Cecilia, Gutiérrez-Aguirre, César Homero, Colunga Pedraza, Perla Rocío, del Carmen Tarín-Arzaga, Luz, Jaime-Pérez, José Carlos, Hawing Zárate, José Angel, González-Cantú, Graciela Alejandra, Villalobos-Gutiérrez, Leonel Estanislao, Jiménez-Castillo, Raúl Alberto, Vera-Pineda, Raymundo, Gómez-Almaguer, David

“…Historically, the measurement of serum procalcitonin (PCT) levels in patients with leukopenia has been rejected without sufficient prospective evidence to…”
Get full text

Pernicious anaemia can be treated effectively with a single high dose of cobalamin by Pezina‐Cantú, César, Gómez‐De León, Andrés, Jaime‐Perez, José C., Colunga‐Pedraza, Perla, Tarín‐Arzaga, Luz, Leija‐Walle, Ramsés, Morcos‐Sandino, Michelle, Gómez‐Almaguer, David

Get full text

Electrophoretical distribution of serum monoclonal protein and underlying causes. Data from a referral center in Mexico by Luz Tarín-Arzaga, Carlos de la Cruz-de la Cruz, Odra Martínez-González, David Gómez-Almaguer

“…Background: Monoclonal gammopathies are a group of disorders characterized by an overproduction of monoclonal immunoglobulin. Detection and quantification of…”
Get full text

Different outcomes for transplant-eligible newly diagnosed multiple myeloma patients in Latin America according to the public versus private management: a GELAMM study by Peña, Camila, Riva, Eloisa, Schutz, Natalia, Tarín-Arzaga, Luz, Martínez-Cordero, Humberto, Bove, Virginia, Osorio, Rocío, Chandía, Mauricio, Beltrán, Cecilia, Schulz, Javier, Cardemil, Daniela, Contreras, Carolina, Vergara, Carmen Gloria, Donoso, Javiera, Espinoza, Marcela, La Rocca, Gabriel, López-Vidal, Hernán, León, Pilar, Rojas Hopkins, Christine, Soto, Pablo, Aranda, Sandra, Torres, Vivianne, Roa, Macarena, Ochoa, Paola, Duarte, Patricio Jose, Remaggi, Guillermina, Yantorno, Sebastián, Corzo, Ariel, Zabaljauregui, Soledad, Shanley, Claudia, Lopresti, Sergio, Orlando, Sergio, Verri, Verónica, Quiroga, Luis, García, Carlos, Fernández, Vanesa, Ramirez, Jhoanna, Molina, Alicia, Pacheco, María, Mite, Alex, Reyes, Inés, Sabando, Brenner, Ramírez, Francisca, Sossa, Claudia, Abello, Virginia, Idrobo, Henry, Galvez Cardenas, Kenny Mauricio, Saavedra, Domingo, Quintero, Guillermo, Gazitúa, Raimundo, Gaviria, Lina, Gomez, Rigoberto, Osuna, Mónica, Henao-Uribe, Alicia, Cantú-Martínez, Omar, Gómez-Almaguer, David, García-Navarrete, Yarely Itzayana, Cruz-Mora, Antonio, Cantero-Fortiz, Yahveth, Ruiz-Argüelles, Guillermo J, Fantl, Dorotea

“…The aim of this study was to describe clinical and survival characteristics of transplant-eligible multiple myeloma (MM) patients in Latin America (LA), with a…”
Get full text

Seek and ye shall find: monoclonal gammopathy of undetermined significance by Luz Tarín-Arzaga, Carlos de la Cruz-de la Cruz, Omar Cantu-Martinez, Odra Martínez-González, David Gómez-Almaguer

“…During the development of a previous study recently published in this journal, where we sought to establish a serum globulins cutoff measured on routinely…”
Get full text

Results of treating relapsed and refractory acute myeloid leukemia at a reference center in Latin America: the importance of outpatient hematopoietic stem cell transplantation by José C. Jaime-Pérez, Ernesto Picón-Galindo, César H. Gutiérrez-Aguirre, Olga G. Cantú-Rodríguez, Andrés Gómez-De León, Perla R. Colunga-Pedraza, Luz Tarín-Arzaga, Dalila M. Alvarado Navarro, David Gómez-Almaguer

Get full text

Diagnosing and treating young multiple myeloma patients. Experience from a tertiary-care center in Mexico by José C. Jaime-Pérez, Carlos de la Cruz-de la Cruz, Luz Tarín-Arzaga, Luis A. González-Torres, David Gómez-Almaguer

“…Background: Multiple myeloma (MM) is an infrequent hematologic entity in patients 40 years or younger, with a clinical presentation and disease course that…”
Get full text

Coexisting Chronic Rhino-Cerebral Mucormycosis and Actinomyces Infection: A Case Report and Review of the Literature by Acuña-Rocha, Victor D, Ramírez-Vázquez, José A, González Torres, Luis A, López-Zamarrón, Jenny C, Tarín-Arzaga, Luz Del Cármen

“…Fungal rhino-orbital-cerebral infections present significant treatment challenges, especially in immunocompromised individuals, such as those with diabetes…”
Get full text

ROC defined serum globulin cutoff as a screening tool for monoclonal gammopathies by Luz Tarín-Arzaga, Omar Cantu-Martinez, Carlos de la Cruz-de la Cruz, Odra L. Martínez-González, Martha A. Reyes-López, José C. Jaime-Pérez, David Gómez-Almaguer

“…Background: Serum protein electrophoresis (SPE), immunofixation, and free light chain assays are recommended for monoclonal gammopathy (MG) screening. High…”
Get full text

Umbilical cord blood transplantation using non-myeloablative conditioning: the Mexican experience by Mancías-Guerra, Consuelo, Ruiz-Delgado, Guillermo J, Manzano, Carlos, Díaz-Hernandez, Maria Angeles, Tarín-Arzaga, Luz C, González-Llano, Oscar, Gómez-Almaguer, David, Ruiz-Argüelles, Guillermo J

“…Twenty-eight children and adults underwent transplantation with allogeneic umbilical cord blood cells (UCB) using a non-ablative conditioning regimen; there…”
Get more information

High response rate to low-dose rituximab plus high-dose dexamethasone as frontline therapy in adult patients with primary immune thrombocytopenia by Gómez-Almaguer, David, Tarín-Arzaga, Luz, Moreno-Jaime, Brizio, Jaime-Pérez, José Carlos, Ceballos-López, Adrián Alejandro, Ruiz-Argüelles, Guillermo J., Ruiz-Delgado, Guillermo J., Cantú-Rodríguez, Olga Graciela, Gutiérrez-Aguirre, Cesar Homero, Sánchez-Cárdenas, Mónica

“…Corticosteroids as initial therapy for primary immune thrombocytopenia achieve a low rate of sustained remission. Methods We prospectively evaluated the…”
Get full text

Correlation between activated partial thromboplastin time and diluted Russell’s viper venom time in the presence of lupus anticoagulant by Luz Tarín-Arzaga, Carlos de la Cruz-de la Cruz, Martha A. Reyes-López, Omar Cantu-Martinez, Karina Vázquez-Hernández, Odra Martínez-González, Luis A. González-Torres, Luis J. Marfil-Rivera, David Gómez-Almaguer

“…Lupus anticoagulant (LA) is a heterogeneous group of antibodies that interfere with phospholipid-dependent coagulation tests, which result in abnormally…”
Get full text

Contributions to the American Society of Hematology Meeting From Low- and Middle-Income Countries: An In-Depth Analysis and Call to Action by Gómez-De León, Andrés, Colunga-Pedraza, Perla R, Tarín-Arzaga, Luz, Bugarín-Estrada, Emmanuel, Sung, Lilian, Cantú-Martínez, Omar, Jaime-Pérez, José C, Gómez-Almaguer, David

“…Establishing research capacity in low- and middle-income countries (LMICs) is key for improving the outcomes of patients with hematologic diseases globally…”
Get full text

Low incidence and severity of graft-versus-host disease after outpatient allogeneic peripheral blood stem cell transplantation employing a reduced-intensity conditioning by Cantú-Rodríguez, Olga G., Gutiérrez-Aguirre, César H., Jaime-Pérez, José C., Treviño-Montemayor, Oscar R., Martínez-Cabriales, Sylvia A., Gómez-Peña, Alvaro, López-Otero, Avril, Ruiz-Delgado, Guillermo J., González-Llano, Oscar, Mancías-Guerra, María C., Tarín-Arzaga, Luz D.C., Rodríguez-Romo, Laura N., Ruiz-Argüelles, Guillermo J., Gómez-Almaguer, David

“…Background:  The prevalence and features of graft‐versus‐host disease (GVHD) in patients receiving allografts using peripheral blood stem cells (PBSCs) after a…”
Get full text